Zydus Cadila first vaccine in India to get approval for kids above 12 years

  • Facebook
  • Twitter
  • Reddit
  • Flipboard
  • Email
  • WhatsApp
Zydus Cadila first vaccine in India to get approval for kids above 12 years (Image: Pixabay)
Zydus Cadila first vaccine in India to get approval for kids above 12 years (Image: Pixabay)

New Delhi : Zydus Cadila’s COVID-19 vaccine, ZyCoV-D, has managed to get an approval for emergency use authorization from the Drug Controller General of India and it will be administered to people above 12 years of age.

With this it has become India's first vaccine that can be administered to the age group of 12-18 years. Prime Minister Narendra Modi called the development a “momentous feat” and said the approval to the world’s first DNA-based vaccine against the coronavirus is a testimony to the innovative zeal of India’s scientists.

“India is fighting COVID-19 with full vigour. The approval for world’s first DNA based ZyCov-D’ vaccine of @ZydusUniverse is a testimony to the innovative zeal of India’s scientists,” Prime Minister Modi tweeted. “A momentous feat indeed,” he added.



ZyCoV-D is a needle-free vaccine administered using ‘PharmaJet’, an applicator that ensures painless intradermal vaccine delivery, Zydus Cadila has said.

Till date India has five vaccines which can be administered to protect people from coronavirus. Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin, Russian vaccine Sputnik V, the vaccines of Moderna, and Johnson and Johnson. Of these, Covishield, Covaxin and Sputnik V are in use in the country.